Viedoc

Executive Summary

Viedoc is a Swedish digital health company specializing in eClinical software for clinical trials, offering a comprehensive suite including Electronic Data Capture (EDC), electronic Patient-Reported Outcomes (ePRO), and Televisits modules. Founded in 2003 and based in Uppsala, the company serves sponsors, CROs, and academic research sites globally, with a focus on streamlining data management, ensuring regulatory compliance, and improving data quality. Despite being a private company with limited public financials, Viedoc has established itself as a reliable partner in the clinical trial ecosystem, particularly in Europe, though it faces competition from larger players like Medidata and Veeva. Looking ahead, Viedoc is well-positioned to benefit from the increasing adoption of decentralized clinical trials and the growing demand for ePRO solutions. Upcoming catalysts include the launch of an upgraded platform with enhanced interoperability and real-time analytics, a potential strategic partnership with a major CRO, and the expansion of its Televisits capabilities for hybrid trial models. With a solid track record and a focus on innovation, Viedoc has the potential to capture market share, though execution risks remain due to competitive pressures and the need for continuous investment in technology.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation platform with AI-powered data validation and interoperability65% success
• Q4 2026Strategic partnership with top 10 CRO for preferred vendor status55% success
• Q2 2026Expansion of decentralized trial capabilities with new Televisits features70% success